Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.

Slides:



Advertisements
Similar presentations
Advances and Emerging Therapy for Lung Cancer
Advertisements

Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
Breast Cancer in Pregnancy
Role of Nodal Irradiation in Breast Cancer
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
The Call (a brief tour of breast cancer) Family Medicine Review Course 2011 Christian Cable, MD, FACP.
Ovarian Cancer Gloria S. Huang, M.D. Assistant Professor Department of Obstetrics & Gynecology and Women ’ s Health Division of Gynecologic Oncology Albert.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Maša Radeljak Mentor: A. Žmegač Horvat
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Multi discipilinary team approach in Breast cancer (1) Fatih Agalar, MD, FACS, FEBS (hon) Prof of Surgery.
Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Breast Conservation Surgery
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Eleni Galani Medical Oncologist
2 years later, she noticed multiple cm
Health Provider Teams: How you can support cancer survivors after treatment Washington CARES about Cancer Partnership: Survivorship Taskforce June 2012.
Meeting goals Provide participants – Current status regarding Classification Diagnosis Management – Update on the latest developments in neuroendocrine.
Endometrial Carcinoma
ONCOLOGY Patient Management. ONCOLOGY Patient management Cancer patient management: Solid tumors Therapeutic decision Clinical findings Cancer diagnosis.
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
ER and PR Test Estrogen and Progesterone receptor status tests will show whether or not one or both of these hormones fuel the tumor Cancer that is hormone-sensitive.
March 2001Management of Thyroid CancerInformation Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
ACRIN 6678 Site Training ACRIN 6678 FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-small Cell Lung.
File #1 Table of Contents Introduction Presenter’s Notes Oncology Rehabilitation: Web-based Learning for Physical Therapists Who Provide Rehabilitation.
1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,
PROSTATE CANCER: RADIATION APPROACHES for advanced disease
Syrian private University Medical Faculty Department of Surgery Principles of cancer surgery M.A.Kubtan, MD-FRCS.
Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
BREAST CANCER Oncology
Evidence Based Approach 5-Year Survival Rate for Breast Cancer Stage IV is 14% 2 to 5 percent become long-term survivors, possibly cured of their disease.
Pre-Operative Therapy for Borderline Resectable Pancreatic Cancer: The Potential Role of Chemotherapy Robert A. Wolff, M.D. Associate Professor of Medicine.
French Guidelines (SOR): Any Impact Since 1995? BN Bui Institut Bergonié, Bordeaux FSG CETOS 2005.
Introduction to Tumor Board
 Define Survivorship  Demonstrate understanding of the history of cancer survivorship  State the requirements of the Commission on Cancer of the American.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Omega Best Cancer Hospital - India
WHO WE ARE PEMBE HANIM IS A TURKISH UMBRELLA CANCER PATIENTS ORGANISATION FOUNDED IN 2010 BY NEVVAL SEVINDI BC SURVIVOR TWICE ,ANTHROPOLOGIST WRITER,
Palliative Care: Emergency Room Interaction
Advanced loco regional Regional breast cancer
Dr Amit Gupta Associate Professor Dept Of Surgery
WHO WE ARE PEMBE HANIM IS A TURKISH UMBRELLA CANCER PATIENTS ORGANISATION FOUNDED IN 2010 BY NEVVAL SEVINDI TWICE BC SURVIVOR TWICE,ANTHROPOLOGIST WRITER,
Bladder Cancer and Prostatic Cancer
THBT neoadjuvant endocrine therapy is to be used in post-menopausal breast cancer woman Antonino Grassadonia Università «G. D’Annunzio» – Chieti-Pescara.
Surgical Cancer Treatment
S1207: Phase III randomized, placebo-controlled trial adding 1 year of everolimus to adjuvant endocrine therapy for patients with high-risk, HR+, HER2-
Perspectives on Triple-Negative Breast Cancer
Pathway for patients with suspected Breast Cancer
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Oncology Tru Miller White 2.
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Neoadjuvant Adjuvant Curative Palliative
Early and locally advanced breast cancer
Pathway for patients with suspected Breast Cancer
Breast Multidisciplinary Team Meetings
Presentation transcript:

Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer

Gaurav Agarwal / Jul 2008 Breast Cancer is best treated in a Multi Disciplinary Manner by a team of experts. All components of such an expert team are available under one roof at SGPGIMS Lucknow Radiation Oncologist Pathologist Radiologist Breast Surgeon SGPGIMSSGPGIMS Medical Oncologist Nuclear Medicine

Gaurav Agarwal / Jul 2008 How is Breast Cancer Managed at SGPGIMS Lucknow, and at major eminent centers around the world Suspected Breast Cancer Confirmation of Diagnosis Staging Treatment Follow-up Identify Recurrence Secondary treatment Complications Surgery, CTx, RTx, HTx Early OperableLocally Advanced Metastatic

Gaurav Agarwal / Jul 2008 Curable In-curable Potentially Curable Early Operable Breast Cancer Staging Breast Cancer is an important initial step in deciding appropriate treatment for an individual patient Patients are staged into three major groups according to stage of disease. The approach to treatment and expected outcomes are very different in these three groups

Gaurav Agarwal / Jul 2008 What are the Treatment Modalities used for treatment of breast cancer For Loco-regional control- i.e. treating the primary cancer in breast and regional disease in lymphatic basin of axilla (arm-pit) Surgery Radiation therapy For Systemic control- i.e. for control of invisible (in early stage cancers) or evident (late stage) disease outside the breast and arm-pit Cyto-toxic chemotherapy Hormonal therapy Immuno-therapy/ other biologicals Almost all modalities are required in almost all patients, though with different intention, and in different sequence

Gaurav Agarwal / Jul 2008 What is an appropriate sequence of various components of Breast cancer Treatment: this varies according to stage groups Biopsy: Cytologic/ histologic Confirmation Staging Early Operable Operation Adjuvant Tt- chemotherapy, radiation, hormone Follow-up Locally Advanced Neo-adjuvant Chemotherapy Surgical Tt Adjuvant Tt Follow-up Metastatic Primary/ salvage Systemic Tt ?Surgical Tt Follow-up